SOURCE: Ventana Medical Systems, Inc.

January 31, 2007 12:06 ET

Ventana to Present at Merrill Lynch

TUCSON, AZ -- (MARKET WIRE) -- January 31, 2007 -- Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced that President and Chief Executive Officer, Christopher Gleeson, will present at the Merrill Lynch 2007 Global Drug, Device and Biotechnology Conference, on Tuesday, February 6, 2007 at 4:00 pm Eastern in New York City at the Grand Hyatt New York.

Ventana develops, manufactures, and markets instrument/reagent systems that automate slide preparation and staining in clinical histology and drug discovery laboratories worldwide. Ventana's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Ventana's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds.

For more information on Ventana Medical Systems, Inc. visit

Contact Information

  • Contact:

    Christopher M. Gleeson
    President and CEO
    (520) 229-3787

    Nick Malden
    Chief Financial Officer
    (520) 229-3857

    1910 E. Innovation Park Drive
    Tucson, Arizona 85755
    (520) 887-2155